Compare ResMed Inc. (RMD) vs TJX Companies Inc (TJX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs TJX Companies Inc — how do they compare? ResMed Inc. trades at $230.05 (market cap $31.89B), while TJX Companies Inc trades at $138.76 (market cap $152.62B). The key difference: TJX Companies Inc is far larger — about 4.8× ResMed Inc.'s market cap, and TJX Companies Inc pays the higher dividend (1.38%). Which is the better fit depends on your goals — on Pluang, investors hold ResMed Inc. for 51 Days and TJX Companies Inc for 97 Days on average.
| RMD | TJX | |
|---|---|---|
Market Cap | $31.89B | $152.62B |
Volume | 618,314 | 8,079,794 |
Sector | Health | Consumer Cyclical |
52-Week High | $275.96 | $168.41 |
52-Week Low | $182.82 | $122.84 |
Typical Hold Time | 51 Days | 97 Days |
Enterprise Value | $31.24B | $160.93B |
Dividend Yield | 1.16% | 1.38% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ResMed (RMD) trades at $226.73, up 0.33% on the day, with a bullish technical signal supported by moving averages. The company reported strong earnings beats in recent quarters, with Q3 2026 results pending. Revenue grew to $5.15 billion in 2025, with a net income margin of 26.94%, while cash flow from operations reached $1.75 billion. Recent news highlights an upcoming earnings report and positive analyst commentary on growth prospects.
The outlook is positive, driven by consistent earnings outperformance and a consensus price target of $242.70, implying upside. Key risks include competitive pressures and ongoing legal investigations. Institutional interest remains strong, with recent stake increases by funds. The stock's valuation metrics, such as a P/E of 21.74, appear reasonable given growth expectations.
TJX trades at $138.75, down 0.04% on the day, with strong fundamental performance including 62.17% ROE and consistent earnings beats. The stock shows bullish technical momentum with support at $136 and resistance at $140. Revenue grew to $56.36B in 2025 with net income reaching $4.86B, while analyst consensus remains overwhelmingly positive with 85% buy ratings.
TJX presents a compelling investment case with projected 28% upside to the $174.15 consensus target, supported by expanding profit margins and robust cash flow generation. Key risks include competitive pressures in off-price retail and potential consumer spending volatility. The company's strong balance sheet and consistent dividend payments provide stability amid market fluctuations.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About TJX Companies Inc
TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →
